Immunogenicity and Safety of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein-Based Vaccine When Co-administered With the Adjuvanted Recombinant Herpes Zoster Subunit Vaccine in Adults >/= 50 Years of Age. (academic.oup.com)

Authors: Roussy JF … Van der Wielen M Journal: Clinical Infectious Diseases Published: 2026-04-29 DOI: https://doi.org/10.1093/cid/ciag208